Clinical trial
Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT03981705
Study timeline
Study start (actual)2019-08-08Date precision: day
Registry last updated2024-12-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
TN ER-/PR-/HER2- Breast Cancerunresolved
Triple Negative Breast Cancerunresolved
HER2-positive Breast Cancerunresolved
ERany/PRany/HER2+ Breast Cancerunresolved
Interventions
Standard Trimodality Breast ImagingRADIATION
Sponsors & collaborators
Masonic Cancer Center, University of Minnesotalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03981705 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.